99 results on '"Sadovnick, Dessa"'
Search Results
2. Prevalence of extracranial venous narrowing on catheter venography in people with multiple sclerosis, their siblings, and unrelated healthy controls: a blinded, case-control study
3. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study
4. The road to conception for women with multiple sclerosis
5. Birth Outcomes in Newborns Fathered by Men with Multiple Sclerosis Exposed to Disease-Modifying Drugs
6. A Review of Safety-Related Pregnancy Data Surrounding the Oral Disease-Modifying Drugs for Multiple Sclerosis
7. Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance
8. Association of dopamine transporter gene variants with childhood ADHD features in bipolar disorder
9. Genetic susceptibility to MS: a second stage analysis in Canadian MS families
10. Term pregnancies and the clinical characteristics of multiple sclerosis: a population based study
11. 2010 McDonald criteria for diagnosing pediatric multiple sclerosis
12. Multiple sclerosis and pregnancy: maternal considerations
13. Rare Variants in the CYP27B1 Gene Are Associated with Multiple Sclerosis
14. Neonatal and delivery outcomes in women with multiple sclerosis
15. Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis1–3
16. A first stage genome-wide screen for regions shared identical-by-descent in hutterite families with multiple sclerosis
17. Suggestive linkage of a chromosomal locus on 18p11 to cyclothymic temperament in bipolar disorder families
18. Depression as a Risk Factor for Alzheimer Disease: The MIRAGE Study
19. Abnormal Frequency and Function of MR1-defined MAIT cells in Pediatric Multiple Sclerosis (S55.007)
20. Abnormal effector and regulatory T cell subsets in paediatric-onset multiple sclerosis
21. Congenital Abnormalities and Multiple Sclerosis
22. Adverse early life events are not associated with pediatric multiple sclerosis (MS) (P3.217)
23. Role of INPP5D, PTK2B, ZCWPW1 and TREM 2 in Predicting Risk of Progression in Cognitively Impaired Subjects to Alzheimer's Disease (P5.166)
24. Puberty in females enhances the risk of an outcome of multiple sclerosis in children and the development of central nervous system autoimmunity in mice
25. Abnormal responses of CD8+CD161high mucosal associated invariant T (MAIT) cells and CCR2+CCR5+ CD4 T cells contribute to disrupted balance of effector and regulatory T cells in pediatric-onset MS
26. Early Clinical and MRI Predictors of Time to Second Attack and Disability in Children with Acute Demyelinating Syndromes: Findings from a Prospective National Cohort Study (S54.007)
27. Phenotypic and Functional Analysis of Immune Cell Subsets in Pediatric-onset Multiple Sclerosis (MS): Towards Definition of Earliest Disease Mechanisms (P2.236)
28. Birth Outcomes In Newborns Fathered By Men With Multiple Sclerosis Exposed To Disease-Modifying Drugs (P4.155)
29. P3–006: Late‐onset Alzheimer's disease genetic risk factors in two Canadian cohorts: CSHA and ACCORD
30. P1-149: Canada-China Cohort Study of early-onset familial Alzheimer's disease
31. Contribution of Genetic Risk Factors in Progression from Cognitive Impairment to Alzheimer Disease in 2 Large Canadian Cohorts (S34.001)
32. Early-onset dementias: diagnostic and etiological considerations
33. O3‐01‐02: Genetic predictors of progression of cognitive impairment in Two large Canadian cohorts: CSHA and ACCORD
34. Congenital Abnormalities and Multiple Sclerosis
35. Biomarkers in Pediatric Multiple Sclerosis: Predicting Recurrent Disease at the Initial Demyelinating Episode
36. A Role for VAV1 in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
37. Serum 25‐hydroxyvitamin D as a determinant of multiple sclerosis outcome following a pediatric demyelinating event
38. Puberty in females enhances the risk of an outcome of multiple sclerosis in children and the development of central nervous system autoimmunity in mice.
39. Abnormal responses of CD8 + CD161high mucosal associated invariant T (MAIT) cells and CCR2 + CCR5 + CD4 T cells contribute to disrupted balance of effector and regulatory T cells in pediatric-onset MS
40. The effect of apolipoprotein E genotypes in Alzheimer's disease: Data from the Canadian study of health and aging
41. Apolipoprotein E genotype as a predictor of progression from cognitively impaired, but not demented to dementia over a 5-year period
42. Late-onset Alzheimer's disease genetic risk factors in two Canadian cohorts: CSHA and ACCORD
43. Canada-China Cohort Study of early-onset familial Alzheimer's disease
44. A Pilot Experience in Genetic Counseling for Alzheimer's Disease.
45. Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review.
46. Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease.
47. Genetic predictors of progression of cognitive impairment in Two large Canadian cohorts: CSHA and ACCORD
48. The increasingly complex genetics of Tourette's syndrome.
49. A Role for VAV1in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
50. The Canadian Multiple Sclerosis Pregnancy Study: First-trimester miscarriages in women with multiple sclerosis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.